Additional file 1. Table composed of three separate sheets. The first sheet reports the analyzed diseases with the corresponding number of disease-causing genes. The second sheet reports the analyzed
Supplementary Table 4. List of Compounds that are predicted to reverse the monocytes signature in SLE, derived from the L1000CDS2 platform-based drug repurposing analysis.
With a continuous threat of antimicrobial resistance on human health worldwide, efforts for new alternatives are ongoing for the management of bacterial infectious diseases. Natural products of land a
